(Iti-007/lumateperone) Intra-Cellular Therapies stock soars 38% premarket after FDA approves

8 Likes
4 Likes

Googling it, there is not a lot of info on the drug itself.

What is the efficacy profile for example? And how does the drug work?

Does it make you fat and have akathisia?

I’ve updated the subject line. It’s iti-007.

2 Likes

Oh, it said Capytla, not lumateperone!

Maybe that’s the “box” name. The drug is called lumateperone. Like abilify and aripiprazole etc.

2 Likes

Now we only have to wait five years for it to get to the UK. :crazy_face:

2 Likes

https://www.nasdaq.com/articles/fda-approves-intra-cellullars-schizophrenia-treatment-shares-soar-2019-12-23

This is exciting, I need to update another thread!

1 Like
2 Likes

Anyone know if lumateperone will be available in Europe? I have to ask my pdoc when I see her next week.

Probably not for another 3 years I suspect.

1 Like

I am happy because its a new option that may benefit many patients. I also own some stock in the company.

2 Likes

Wow! Good call ! You made a bit of money today then !

1 Like

does anyone know, if you are in the UK and you go to a private Psychiatrist and pay for lumateperone privately, can you get it in the UK or Europe?

No you have to wait 3 years until it’s approved by the EMA.

1 Like

What about if I lived in South America?

Lol. No idea. :thinking:

1 Like

I googled it and Argentina is around 10 months from a USA patented/marketed drug.

1 Like

side effect profile same with other antipsychotics